Eiken Chemical Co Ltd
TSE:4549
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
RioCan Real Estate Investment Trust
TSX:REI.UN
|
CA |
Eiken Chemical Co Ltd
Operating Income
Eiken Chemical Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Eiken Chemical Co Ltd
TSE:4549
|
Operating Income
¥3.1B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-1%
|
|
|
Hoya Corp
TSE:7741
|
Operating Income
¥271.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
|
H
|
Hogy Medical Co Ltd
TSE:3593
|
Operating Income
¥2.5B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-12%
|
|
|
A
|
Asahi Intecc Co Ltd
TSE:7747
|
Operating Income
¥26B
|
CAGR 3-Years
15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
|
Mani Inc
TSE:7730
|
Operating Income
¥11.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
11%
|
|
|
Nipro Corp
TSE:8086
|
Operating Income
¥31.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Eiken Chemical Co Ltd
Glance View
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. The company is headquartered in Taito-Ku, Tokyo-To and currently employs 733 full-time employees. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
See Also
What is Eiken Chemical Co Ltd's Operating Income?
Operating Income
3.1B
JPY
Based on the financial report for Dec 31, 2025, Eiken Chemical Co Ltd's Operating Income amounts to 3.1B JPY.
What is Eiken Chemical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-1%
Over the last year, the Operating Income growth was 21%. The average annual Operating Income growth rates for Eiken Chemical Co Ltd have been -29% over the past three years , -12% over the past five years , and -1% over the past ten years .